News
Fat cells are also metabolically active and can cause a chronic state of inflammation in the part of the body where they ...
Gyre Therapeutics, Inc. (NASDAQ:GYRE), a biopharmaceutical company developing innovative fibrosis-focused therapies, has ...
Altimmune nears a key MASH trial readout, with strong market potential and new liver and alcohol studies supporting growth.
A recommended 150 minutes per week at moderate intensity can help reduce liver inflammation and rid the organ of fat. Antioxidants and other compounds in coffee (even decaf) can help protect against ...
A study in weight loss drugs where one third of participants were given a placebo turned out to have some impressive results.
Arrowhead Pharmaceuticals, Inc.'s deal with Sarepta expands its pipeline, but limited plozasiran market and competition ...
Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, ...
8h
News Medical on MSNAdvanced organoid model recreates complex liver architectureThe liver has a unique structure, especially at the level of individual cells. Hepatocytes, the main liver cells, release ...
The liver has a unique structure, especially at the level of individual cells. Hepatocytes, the main liver cells, release ...
Metabolic dysfunction-associated steatotic liver disease in pregnant women is a risk factor for preterm birth.
Non-alcoholic steatohepatitis (NASH), a severe form of fatty liver disease, is projected to become the leading cause of liver ...
1h
The Mirror US on MSNCommon supplement linked to brutal liver injury as patient issues warningIt turns out I had something called a drug-induced liver injury, which came from my supplements.” It wasn’t revealed exactly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results